The group of technologies that enable gene editing help scientists modify an organism's DNA. Let's look at one of the more prominent pure-play gene-editing stocks on the market: Editas Medicine (NASDAQ: EDIT). This company recently took a nosedive following a disappointing clinical update.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting